Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma
Journal of Clinical Investigation · 01.04.2025 · 135 (7)
DOI: 10.1172/jci177724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 11.02.2025. Verfasst von Jiawen Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona Cancer Center, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Pyrvinium Compounds, Wnt Signaling Pathway, Skin Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cutaneous malignancy arising from either ultraviolet-induced mutagenesis or Merkel cell polyomavirus (MCPyV) integration. Despite extensive research, our understanding of the molecular mechanisms driving the transition from normal cells to MCC remains limited. To address this knowledge gap, we assessed the impact of inducible MCPyV T antigens on normal human fibroblasts by performing RNA-seq. Our data uncovered changes in expression and regulation of Wnt signaling pathway members. Building on this observation, we bioinformatically evaluated various Wnt pathway perturbagens for their ability to reverse the MCC gene expression signature and identified pyrvinium pamoate, an FDA-approved anthelminthic drug known for its antitumor activity in other cancers. Leveraging transcriptomic, network, and molecular analyses, we found that pyrvinium targets multiple MCC vulnerabilities. Pyrvinium not only reverses the neuroendocrine features of MCC by modulating canonical and noncanonical Wnt signaling but also inhibits cancer cell growth by activating p53-mediated apoptosis, disrupting mitochondrial function, and inducing endoplasmic reticulum stress. Finally, we demonstrated that pyrvinium reduces tumor growth in an MCC mouse xenograft model. These findings offer a deeper understanding of the role of Wnt signaling in MCC and highlight the utility of pyrvinium as a potential treatment for MCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Arizona Cancer Center, Tucson, Arizona, USA.
- Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.
- Department of Pharmacology and Toxicology, The University of Arizona R. Ken Coit College of Pharmacy, Skaggs Pharmaceutical Sciences Center, Tucson, Arizona, USA.
- Department of Epidemiology and Biostatistics, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.
- The University of Arizona College of Medicine, Tucson, Arizona, USA.
- The University of Arizona, BIO5 Institute, Tucson, Arizona, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Yang, J., Lim, J. T., Santiago Raj, P. V., Corona, M. G., Chen, C., Khawaja, H., Pan, Q., Paine-Murrieta, G. D., Schnellmann, R. G., Roe, D. J., Gokhale, P. C., DeCaprio, J. A., & Padi, M. (2025). Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma. Journal of Clinical Investigation, 135(7). https://doi.org/10.1172/jci177724
Vancouver
Yang J, Lim JT, Santiago Raj PV, Corona MG, Chen C, Khawaja H, et al. Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma. Journal of Clinical Investigation. 2025;135(7). doi:10.1172/jci177724
BibTeX
@article{Yang2025,
author = {Yang, Jiawen and Lim, James T and Santiago Raj, Paul Victor and Corona, Marcelo G and Chen, Chen and Khawaja, Hunain and Pan, Qiong and Paine-Murrieta, Gillian D and Schnellmann, Rick G and Roe, Denise J and Gokhale, Prafulla C and DeCaprio, James A and Padi, Megha},
title = {Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {7},
doi = {10.1172/jci177724}
}
EUVIMED